177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-7364
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
177Lu-DOTA-0-Tyr3-octreotate infusion modeling for real-time detection and characterization of extravasation during PRRT ; volume:9 ; number:1 ; day:3 ; month:5 ; year:2022 ; pages:1-16 ; date:12.2022
EJNMMI Physics ; 9, Heft 1 (3.5.2022), 1-16, 12.2022
- Creator
-
Mazzara, Christophe
Salvadori, Julien
Ritzenthaler, Florian
Martin, Simon
Porot, Clémence
Imperiale, Alessio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-022-00466-y
- URN
-
urn:nbn:de:101:1-2022071120123560016555
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mazzara, Christophe
- Salvadori, Julien
- Ritzenthaler, Florian
- Martin, Simon
- Porot, Clémence
- Imperiale, Alessio
- SpringerLink (Online service)
Other Objects (12)
![Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC](/assets/placeholder/searchResultMediaUnknown.png)
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
177Lu-DOTA-Octreotat bei Radiorezeptortherapie neuroendokriner Tumore: intratherapeutische Dosimetrie und Eliminationskinetik
Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
The effects of temperament type on infusion extravasation in newborns
Fernmetastasierte neuroendokrine Tumoren des Pankreas: Ansprechen auf Radiopeptidtherapie mit 177Lu-DOTA-Octreotat
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
177Lu-DOTA-Octreotat bei Radiorezeptortherapie neuroendokriner Tumore: intratherapeutische Dosimetrie und Eliminationskinetik
Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
The effects of temperament type on infusion extravasation in newborns
Fernmetastasierte neuroendokrine Tumoren des Pankreas: Ansprechen auf Radiopeptidtherapie mit 177Lu-DOTA-Octreotat
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
Extravasation of a Percutaneous Femoral Hepatic Infusion Device
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy
177Lu-DOTA-Octreotat bei Radiorezeptortherapie neuroendokriner Tumore: intratherapeutische Dosimetrie und Eliminationskinetik
Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour
The effects of temperament type on infusion extravasation in newborns
Fernmetastasierte neuroendokrine Tumoren des Pankreas: Ansprechen auf Radiopeptidtherapie mit 177Lu-DOTA-Octreotat
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases